MRI features predict tumor grade in isocitrate dehydrogenase (IDH)-mutant astrocytoma and oligodendroglioma.

David A JoynerJohn GarrettPrem P BatchalaBharath RamaJoshua R RaviczJames T PatrieMaria-B LopesCamilo E FadulDavid SchiffRajan JainSohil H Patel

Published in: Neuroradiology (2022)

Contrast enhancement predicts WHO grade for IDH-mutant astrocytomas and oligodendrogliomas. ADC and rCBV predict WHO grade for IDH-mutant astrocytomas, but not for oligodendrogliomas.

Keyphrases

wild type
contrast enhanced
diffusion weighted imaging
magnetic resonance imaging
low grade
magnetic resonance
diffusion weighted